{"transactions":[{"id":814410,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":53584,"kind":"person","name":"Hoge Elizabeth","position":1,"cik":"0002000987","reported_name":"Hoge Elizabeth","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53585,"kind":"organization","name":"Seven One Eight Three Four Irrevocable Trust","position":2,"cik":"0002000959","reported_name":"Seven One Eight Three Four Irrevocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2026-04-06T20:28:25.000Z","date":"2026-04-02","kind":"exercise","planned":false,"acquired":false,"shares":22740.03,"ownership":{"direct":false,"nature":"as trustee"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On April 2, 2026, Seven One Eight Three Four Irrevocable Trust (the \"Trust\") elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 13, 2023, the issuer acquired the private Delaware corporation which was then known as Cartesian Therapeutics, Inc. in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023 (the \"Merger\"). These securities represent merger consideration payable as a result of the closing of the Merger and securities purchased in a private placement in November 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 2, 2026, Seven One Eight Three Four Irrevocable Trust (the \"Trust\") elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 2, 2026, Seven One Eight Three Four Irrevocable Trust (the \"Trust\") elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by the Trust. The reporting person is a trustee of the Trust."}],"balance_after":33662.224,"derivative":{"underlying":"Common Stock","underlying_shares":758001},"source":{"system":"sec-edgar","filing":"0002064832-26-000149","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000206483226000149/form4.xml","form_type":"4"}},{"id":814409,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":53584,"kind":"person","name":"Hoge Elizabeth","position":1,"cik":"0002000987","reported_name":"Hoge Elizabeth","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53585,"kind":"organization","name":"Seven One Eight Three Four Irrevocable Trust","position":2,"cik":"0002000959","reported_name":"Seven One Eight Three Four Irrevocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-06T20:28:25.000Z","date":"2026-04-02","kind":"exercise","planned":false,"acquired":true,"shares":758001,"ownership":{"direct":false,"nature":"as trustee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 2, 2026, Seven One Eight Three Four Irrevocable Trust (the \"Trust\") elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by the Trust. The reporting person is a trustee of the Trust."}],"balance_after":5313261,"source":{"system":"sec-edgar","filing":"0002064832-26-000149","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000206483226000149/form4.xml","form_type":"4"}},{"id":1386650,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":53584,"kind":"person","name":"Hoge Elizabeth","position":1,"cik":"0002000987","reported_name":"Hoge Elizabeth","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53585,"kind":"organization","name":"Seven One Eight Three Four Irrevocable Trust","position":2,"cik":"0002000959","reported_name":"Seven One Eight Three Four Irrevocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-10-15T20:43:23.000Z","date":"2024-10-11","kind":"exercise","planned":false,"acquired":false,"shares":45551.19,"ownership":{"direct":false,"nature":"as trustee"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 11, 2024, Seven One Eight Three Four Irrevocable Trust (the \"Trust\") elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 13, 2023, the issuer acquired the private Delaware corporation which was then known as Cartesian Therapeutics, Inc. in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023 (the \"Merger\"). These securities represent merger consideration payable as a result of the closing of the Merger and securities purchased in a private placement in November 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 11, 2024, Seven One Eight Three Four Irrevocable Trust (the \"Trust\") elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 11, 2024, Seven One Eight Three Four Irrevocable Trust (the \"Trust\") elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by the Trust. The reporting person is a trustee of the Trust."}],"balance_after":56402.254,"derivative":{"underlying":"Common Stock","underlying_shares":1518373},"source":{"system":"sec-edgar","filing":"0001062993-24-017675","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000106299324017675/form4.xml","form_type":"4"}},{"id":1386649,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":53584,"kind":"person","name":"Hoge Elizabeth","position":1,"cik":"0002000987","reported_name":"Hoge Elizabeth","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53585,"kind":"organization","name":"Seven One Eight Three Four Irrevocable Trust","position":2,"cik":"0002000959","reported_name":"Seven One Eight Three Four Irrevocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-15T20:43:23.000Z","date":"2024-10-11","kind":"exercise","planned":false,"acquired":true,"shares":1518373,"ownership":{"direct":false,"nature":"as trustee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2024, Seven One Eight Three Four Irrevocable Trust (the \"Trust\") elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by the Trust. The reporting person is a trustee of the Trust."}],"balance_after":4555260,"source":{"system":"sec-edgar","filing":"0001062993-24-017675","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000106299324017675/form4.xml","form_type":"4"}},{"id":1543695,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":53584,"kind":"person","name":"Hoge Elizabeth","position":1,"cik":"0002000987","reported_name":"Hoge Elizabeth","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53585,"kind":"organization","name":"Seven One Eight Three Four Irrevocable Trust","position":2,"cik":"0002000959","reported_name":"Seven One Eight Three Four Irrevocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-04-10T20:20:40.000Z","date":"2024-04-08","kind":"exercise","planned":false,"acquired":false,"shares":14755.609,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer (\"Series A Preferred Stock\") into shares of common stock of the issuer (\"Common Stock\"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer (\"Series A Preferred Stock\") into shares of common stock of the issuer (\"Common Stock\"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer (\"Series A Preferred Stock\") into shares of common stock of the issuer (\"Common Stock\"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":491853},"source":{"system":"sec-edgar","filing":"0001062993-24-008251","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000106299324008251/form4.xml","form_type":"4"}},{"id":1543694,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":53584,"kind":"person","name":"Hoge Elizabeth","position":1,"cik":"0002000987","reported_name":"Hoge Elizabeth","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53585,"kind":"organization","name":"Seven One Eight Three Four Irrevocable Trust","position":2,"cik":"0002000959","reported_name":"Seven One Eight Three Four Irrevocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-04-10T20:20:40.000Z","date":"2024-04-08","kind":"exercise","planned":false,"acquired":false,"shares":87802.95,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer (\"Series A Preferred Stock\") into shares of common stock of the issuer (\"Common Stock\"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer (\"Series A Preferred Stock\") into shares of common stock of the issuer (\"Common Stock\"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer (\"Series A Preferred Stock\") into shares of common stock of the issuer (\"Common Stock\"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned directly by Seven One Eight Three Four Irrevocable Trust (the \"Trust\"). The reporting person is a trustee and beneficiary of the Trust."}],"balance_after":101953.444,"derivative":{"underlying":"Common Stock","underlying_shares":2926764},"source":{"system":"sec-edgar","filing":"0001062993-24-008251","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000106299324008251/form4.xml","form_type":"4"}},{"id":1543693,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":53584,"kind":"person","name":"Hoge Elizabeth","position":1,"cik":"0002000987","reported_name":"Hoge Elizabeth","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53585,"kind":"organization","name":"Seven One Eight Three Four Irrevocable Trust","position":2,"cik":"0002000959","reported_name":"Seven One Eight Three Four Irrevocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-10T20:20:40.000Z","date":"2024-04-08","kind":"exercise","planned":false,"acquired":true,"shares":491853,"ownership":{"direct":false,"nature":"by spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer (\"Series A Preferred Stock\") into shares of common stock of the issuer (\"Common Stock\"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."}],"balance_after":506377,"source":{"system":"sec-edgar","filing":"0001062993-24-008251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000106299324008251/form4.xml","form_type":"4"}},{"id":1543692,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":53584,"kind":"person","name":"Hoge Elizabeth","position":1,"cik":"0002000987","reported_name":"Hoge Elizabeth","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53585,"kind":"organization","name":"Seven One Eight Three Four Irrevocable Trust","position":2,"cik":"0002000959","reported_name":"Seven One Eight Three Four Irrevocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-10T20:20:40.000Z","date":"2024-04-08","kind":"exercise","planned":false,"acquired":true,"shares":2926764,"ownership":{"direct":false,"nature":"as trustee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer (\"Series A Preferred Stock\") into shares of common stock of the issuer (\"Common Stock\"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned directly by Seven One Eight Three Four Irrevocable Trust (the \"Trust\"). The reporting person is a trustee and beneficiary of the Trust."}],"balance_after":3036887,"source":{"system":"sec-edgar","filing":"0001062993-24-008251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000106299324008251/form4.xml","form_type":"4"}}]}